FDA Inspection 556188 — Janssen Pharmaceuticals Inc.
The FDA completed an inspection of Janssen Pharmaceuticals Inc. on Jan 15, 2009 in Raritan, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 15, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Raritan, NJ (United States)